Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allosteric agonist modulators.

Terry Kenakin1

  • 1Biochemical Reagents and Assay Development, GlaxoSmithKline Research and Development, Research Triangle Park, North Carolina 27709, USA. Terry.P.Kenakin@gsk.com

Journal of Receptor and Signal Transduction Research
|September 22, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biased Signaling as Allosteric Probe Dependence: Everything Old Is New Again.

Biochemistry·2026
Same author

Therapeutic implications of target residence time.

Current opinion in structural biology·2026
Same author

Structure-based design of an opioid receptor modulator for enhanced morphine analgesia.

Science advances·2026
Same author

Differential Effects of Sodium on Agonist-Induced Conformational Transitions and Signaling at μ and κ Opioid Receptors.

Biochemistry·2025
Same author

Agonism and Biased Signaling.

Handbook of experimental pharmacology·2025
Same author

Differential effects of sodium on agonist-induced conformational transitions and signaling at μ and κ opioid receptors.

bioRxiv : the preprint server for biology·2025
Same journal

<i>In silico</i> investigation of Panchagavya Ghrita's anticancer potential against glioblastoma: a network pharmacology and molecular docking study.

Journal of receptor and signal transduction research·2026
Same journal

Molecular insights into voltage-gated sodium channels in excitable cells: pathophysiological roles and emerging therapeutic targets.

Journal of receptor and signal transduction research·2026
Same journal

β<sub>1</sub>/β<sub>2</sub> adrenergic dysregulation: a missing link between mitochondrial fission/fusion in the failing heart.

Journal of receptor and signal transduction research·2026
Same journal

Targeting vascular endothelial growth factor and its receptors in non-small cell lung cancer for improved treatment strategies.

Journal of receptor and signal transduction research·2026
Same journal

Discrepancies in β-adrenergic receptor signaling and cAMP pathway in high-fat simple carbohydrate diet-fed C57BL/6J mice: implications for metabolic syndrome pathophysiology.

Journal of receptor and signal transduction research·2026
Same journal

Role of selective U-II receptor antagonists in modifying vascular function in intact and denuded aortic diabetic rats.

Journal of receptor and signal transduction research·2026
See all related articles

This study introduces a model for molecules acting as direct agonists and modifying endogenous agonist responses. It details their impact on high-throughput screening and dose-response curves.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Biochemistry

Background:

  • Receptor signaling is complex, involving endogenous agonists and modulatory molecules.
  • Understanding molecules that bind to allosteric sites is crucial for drug discovery.
  • Direct agonism and modulation of endogenous responses present unique pharmacological profiles.

Purpose of the Study:

  • To present a model describing molecules with dual activity: direct agonism and modulation of endogenous agonists.
  • To analyze the impact of these molecules in high-throughput screening (HTS) assays.
  • To investigate their effects on the dose-response curves of conventional agonists.

Main Methods:

  • Development of a theoretical model for allosteric modulators with direct agonist activity.

Related Experiment Videos

  • Simulation of compound effects in high-throughput screening assay contexts.
  • Analysis of dose-response curve modifications induced by these compounds.

    • Main Results:

    • The model accurately predicts the behavior of molecules exhibiting direct agonism and potentiation/antagonism.
    • High-throughput screening assays can detect these dual-acting molecules, but require careful interpretation.
    • These compounds significantly alter conventional agonist dose-response curves, potentially leading to misinterpretation without proper modeling.

    Conclusions:

    • A unified model is essential for understanding complex receptor ligands.
    • Accurate characterization of direct agonists and modulators is critical for drug development.
    • This work provides a framework for interpreting screening data involving novel pharmacological agents.